FDA Finalizes Chagas Disease Guidance for Blood Collection Establishments
By Zachary Brennan -
Published 05 December 2017
The US Food and Drug Administration (FDA) on Tuesday finalized guidance on the use of serological tests to reduce the risk of transmission of T. cruzi, a parasite that causes Chagas Disease, in blood and blood components.
Categories: News, US, CBER, Blood, Compliance
Tags: Chagas Disease, blood collection, FDA guidance